Pharmaceutical Preparations Industry - SEC Form 4 Insider Trading Screener

Manufacturing Sector - Chemicals - Pharmaceutical Preparations
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
100 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Company

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-09-15
PETXAratana Therapeutics, Inc.Heinen ErnstChief Development OfficerS - Sale$6.25-10,000130,994-7%-$62,500
2017-09-19
ATHXAthersys, Inc / NewLehmann William JrPres, COOS - Sale$2.38-15,000512,380-3%-$35,726
M
2017-09-15
ATHXAthersys, Inc / NewHarrington John JExec Vice Pres, CSOS - Sale$2.17-15,000665,974-2%-$32,508
2017-09-18
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.28+3,0003,865,6960%+$835
D
2017-09-18
DERMDermira, Inc.Wiggans Thomas GCEO, COBS - Sale+OE$27.51-9,500144,607-6%-$261,336
D
2017-09-15
BMRNBiomarin Pharmaceutical IncLawlis V BryanDirS - Sale+OE$91.26-3,75015,910-19%-$342,225
D
2017-09-15
BMRNBiomarin Pharmaceutical IncFuchs Henry JPres, Worldwide R, DS - Sale+OE$90.50-15,000136,422-10%-$1,357,500
M
2017-09-14
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+35,00023,486,1890%+$915
2017-09-18
SNNASienna Biopharmaceuticals, Inc.Fenton Dennis MDirP - Purchase$22.96+1,2501,250New+$28,698
2017-09-18
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.00+40,000187,774,4560%+$240,000
2017-09-18
NBRVNabriva Therapeutics PlcVivo Capital Viii, LLC10%P - Purchase$9.46+52,6314,074,190+1%+$497,889
M
2017-03-29
AGNAllergan PlcSaunders Brent LCOB, Pres, CEOP - Purchase$239.04+86131,1780%+$20,626
2017-09-15
MRTXMirati Therapeutics, Inc.Christensen JamieSVP, Chief Science OfficerS - Sale$12.00-7702,670-22%-$9,240
AM
2017-09-13
KALVKalvista Pharmaceuticals, Inc.Novo Holdings A/s10%S - Sale$7.21-176,6442,725,283-6%-$1,273,956
2017-09-18
GLYCGlycomimetics IncThackray Helen M.SVP Clinical Development, CMOS - Sale$13.00-2,000150,615-1%-$26,000
2017-09-15
LFVNLifevantage CorpLewis DarwinDirP - Purchase$4.29+3,5003,500New+$15,015
2017-09-15
LFVNLifevantage CorpMauro Garry PaulDirP - Purchase$4.20+3,50058,640+6%+$14,700
D
2017-09-14
CNCEConcert Pharmaceuticals, Inc.Lynch RyanPFO, PAOS - Sale+OE$14.51-3,5006,000-37%-$50,785
2017-09-15
CLVSClovis Oncology, Inc.Ivers-Read Gillian CSee RemarksS - Sale$69.50-3,000191,583-2%-$208,500
2017-09-18
EPZMEpizyme, Inc.Mott David MDirP - Purchase$15.25+200,0006,467,502+3%+$3,050,000
D
2017-09-15
KPTIKaryopharm Therapeutics Inc.Mirza Mansoor RazaDirS - Sale+OE$11.00-2,8820-100%-$31,702
2017-09-15
KPTIKaryopharm Therapeutics Inc.Primiano Christopher BrettSVP, OPS, BUS DEV, GC, SECS - Sale$11.00-2,00012,881-13%-$22,000
2017-09-15
LLYLilly Eli & CoLilly Endowment Inc10%S - Sale$82.53-190,000123,675,8040%-$15,679,772
2017-09-13
IMGNImmunogen IncBerkenblit AnnaVP, Chief Medical OfficerS - Sale$7.00-1,500161,800-1%-$10,500
2017-09-15
LXRXLexicon Pharmaceuticals, Inc.Coats LonnelPres, CEOP - Purchase$12.54+30,00032,985>999%+$376,337
2017-09-15
LXRXLexicon Pharmaceuticals, Inc.Barker Sam LDirP - Purchase$12.50+1,00025,623+4%+$12,500
2017-09-15
OPKOpko Health, Inc.Logal AdamSVP, CFOP - Purchase$6.03+1,500162,793+1%+$9,045
2017-09-15
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$6.01+80,000187,734,4560%+$480,411
DM
2017-09-13
PAHCPhibro Animal Health CorpJohnson Richard GCFOS - Sale+OE$36.30-55,5290-100%-$2,015,473
DM
2017-09-13
PAHCPhibro Animal Health CorpMiller Larry LeeCOOS - Sale+OE$36.43-21,4390-100%-$781,000
M
2017-09-13
KALVKalvista Pharmaceuticals, Inc.Novo Holdings A/s10%S - Sale$7.21-176,6472,725,280-6%-$1,273,980
2017-09-14
FGENFibrogen IncYu K PeonyChief Medical OfficerS - Sale$51.00-2,851185,546-2%-$145,401
2017-09-13
FGENFibrogen IncRiggs Rory BDirS - Sale$51.92-25,0001,040,913-2%-$1,298,000
M
2017-09-13
FGENFibrogen IncNeff Thomas BCEOS - Sale$51.67-38,6363,479,067-1%-$1,996,274
DM
2017-08-31
FLXNFlexion Therapeutics IncDeniz YamoChief Medical OfficerP - Purchase$24.48+5,3759,000+148%+$131,575
M
2017-09-13
CLSDClearside Biomedical, Inc.Thorp ClayDir, 10%S - Sale$7.52-24,5003,871,394-1%-$184,185
2017-09-13
LOXOLoxo Oncology, Inc.Naider Avi Z.DirS - Sale$90.00-5,000154,118-3%-$450,000
M
2017-09-13
AGIOAgios Pharmaceuticals IncCantley Lewis Clayton Jr.DirS - Sale$65.59-4,000212,434-2%-$262,360
DM
2017-09-14
MACKMerrimack Pharmaceuticals IncNielsen Ulrik B.DirS - Sale+OE$14.23-7,89622,681-26%-$112,357
2017-09-14
VTLVital Therapies IncHasnain FaheemDirP - Purchase$4.19+59,200185,443+47%+$247,870
2017-09-11
MTNBMatinas Biopharma Holdings, Inc.Mannino Raphael JChief Scientific OfficerP - Purchase$1.41+5,0001,424,5650%+$7,050
DM
2017-09-12
AVDLAvadel Pharmaceuticals PlcHatten Sandra LSee RemarksP - Purchase$9.25+6,00041,200+17%+$55,525
D
2017-09-14
UTHRUnited Therapeutics CorpRothblatt Martine ACOB, CEOS - Sale+OE$122.08-1,258674,4870%-$153,575
DM
2017-09-13
IMGNImmunogen IncBarrows CraigEVP, GCS - Sale+OE$6.81-37,05044,050-46%-$252,457
M
2017-09-13
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$33.45+150,0005,498,799+3%+$5,017,975
M
2017-09-13
KMPHKempharm, IncDelaware Street Capital Master Fund, L.P.10%P - Purchase$3.27+325,8881,791,631+22%+$1,066,827
2017-09-14
RDUSRadius Health, Inc.Carmona JoseCFOP - Purchase$32.83+3,0003,000New+$98,503
2017-09-15
RDUSRadius Health, Inc.Hoiland JesperPres, CEOP - Purchase$32.72+6,1006,100New+$199,608
2017-09-14
OPKOpko Health, Inc.Frost Phillip Md Et AlCEO, COB, 10%P - Purchase$5.98+260,000187,654,4560%+$1,555,624
2017-09-13
ADROAduro Biotech, Inc.Isaacs Stephen TPres, CEOS - Sale$10.99-12,204244,578-5%-$134,071
2017-09-13
ADROAduro Biotech, Inc.Schafer Gregory WCOOS - Sale$10.99-4,859148,745-3%-$53,380
2017-09-13
ADROAduro Biotech, Inc.Brockstedt Dirk G.EVP of Research, Dev.S - Sale$10.99-3,55773,718-5%-$39,076
2017-09-13
ADROAduro Biotech, Inc.Lew JenniferSVP of FinanceS - Sale$10.99-3,55762,338-5%-$39,076
2017-09-13
ADROAduro Biotech, Inc.Van Elsas AndreaChief Scientific OfficerS - Sale$10.99-4,922207,231-2%-$54,072
2017-09-13
ADROAduro Biotech, Inc.Templeman BlaineEVP, GCS - Sale$10.99-3,55761,718-5%-$39,076
M
2017-09-12
NBRVNabriva Therapeutics PlcHbm Healthcare Investments (Cayman) Ltd.10%S - Sale$8.56-36,6082,334,128-2%-$313,415
M
2017-09-12
VTLVital Therapies IncSatter Muneer ADir, 10%P - Purchase$4.01+130,00011,132,277+1%+$521,229
2017-09-12
PRGOPerrigo Co PlcJanish Ronald CraigEVP, Global Op., Supply ChainS - Sale$88.71-2615,972-4%-$23,154
2017-09-12
PRGOPerrigo Co PlcNeedham JeffreyEVP, Pres CHC AmericasS - Sale$89.49-3,5959,718-27%-$321,707
M
2017-09-12
EBSEmergent Biosolutions Inc.El-Hibri FuadCOB, 10%S - Sale$38.50-25,0007,448,6210%-$962,500
A
2017-06-29
KDMNKadmon Holdings, Inc.Goldentree Asset Management LP10%S - Sale$4.04-64,4151,270,115-5%-$260,546
D
2017-09-13
AVDLAvadel Pharmaceuticals PlcThompson Phillandas T.See RemarksP - Purchase$9.36+5,00063,000+9%+$46,800
D
2017-09-12
AVDLAvadel Pharmaceuticals PlcStapleton Craig RDirP - Purchase$9.52+20,000633,878+3%+$190,360
D
2017-09-12
AVDLAvadel Pharmaceuticals PlcDivis Greg JSee RemarksP - Purchase$9.32+10,60010,600New+$98,760
D
2017-09-12
AVDLAvadel Pharmaceuticals PlcAnderson Michael SCEOP - Purchase$9.79+4,000229,750+2%+$39,180
D
2017-09-12
CELGCelgene Corp /de/Kaplan GillaDirS - Sale+OE$141.56-9,25076,301-11%-$1,309,430
2017-09-13
VTLVital Therapies IncBienaime Jean JacquesDirP - Purchase$4.00+10,00065,119+18%+$39,969
2017-09-14
SBPHSpring Bank Pharmaceuticals, Inc.Driscoll Martin JPres, CEOP - Purchase$14.84+1,00055,400+2%+$14,840
M
2017-09-12
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+70,00023,451,1890%+$1,788
M
2017-09-08
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+89,00023,381,1890%+$2,269
2017-09-13
AMARAmarillo Biosciences IncChen Stephen TPres, CEO, COB, 10%P - Purchase$0.27+1,0003,862,6960%+$272
2017-09-12
PFEPfizer IncSusman SallyEVPS - Sale$35.00-38,230115,730-25%-$1,338,050
2017-09-12
JAZZJazz Pharmaceuticals PlcCozadd Bruce CCOB, CEOS - Sale$153.52-1,000277,6640%-$153,520
2017-09-11
FGENFibrogen IncCotroneo PatVP, Finance, CFOS - Sale$49.45-2,851157,405-2%-$140,982
2017-09-11
SCMPSucampo Pharmaceuticals, Inc.Ueno Ryuji10%S - Sale$12.00-1,000,0008,006,585-11%-$12,000,000
2017-09-11
SCMPSucampo Pharmaceuticals, Inc.Kuno Sachiko10%S - Sale$12.00-1,000,0007,137,344-12%-$12,000,000
DM
2017-09-11
MACKMerrimack Pharmaceuticals IncNielsen Ulrik B.DirS - Sale+OE$14.40-21,55622,681-49%-$310,408
D
2017-09-11
ALKSAlkermes Plc.Biberstein Kathryn LEVP, CAO, CCO Alks Inc; Sec ALS - Sale+OE$51.29-13,566150,889-8%-$695,817
D
2017-09-11
AGIOAgios Pharmaceuticals IncBowden ChristopherChief Medical OfficerS - Sale+OE$65.00-6,000881-87%-$390,000
2017-09-11
AGIOAgios Pharmaceuticals IncBiller ScottChief Scientific OfficerS - Sale$65.00-15,00016,734-47%-$975,000
D
2017-09-11
KPTIKaryopharm Therapeutics Inc.Mirza Mansoor RazaDirS - Sale+OE$11.00-1180-100%-$1,298
2017-09-12
RDUSRadius Health, Inc.Biotech Growth N V10%P - Purchase$35.42+50,0005,348,799+1%+$1,770,820
DM
2017-09-08
PAHCPhibro Animal Health CorpMiller Larry LeeCOOS - Sale+OE$36.33-46,1020-100%-$1,674,693
DM
2017-09-08
PAHCPhibro Animal Health CorpJohnson Richard GCFOS - Sale+OE$36.32-47,2640-100%-$1,716,456
D
2017-09-11
PAHCPhibro Animal Health CorpCarlson Gerald KDirS - Sale+OE$36.27-5,4000-100%-$195,858
2017-09-12
PTGXProtagonist Therapeutics, IncShames Richard S.Chief Medical OfficerS - Sale$14.31-3,6870-100%-$52,753
D
2017-09-11
ABBVAbbvie Inc.Saleki-Gerhardt AzitaSVP, OperationsS - Sale+OE$85.02-8,30090,590-8%-$705,655
2017-09-08
VTLVital Therapies IncSatter Muneer ADir, 10%P - Purchase$3.53+50,00011,002,2770%+$176,615
2017-09-12
LFVNLifevantage CorpJensen Darren JayCEOP - Purchase$4.22+2,400149,358+2%+$10,126
M
2017-09-08
MYOKMyokardia IncThird Rock Ventures Ii, L.P.10%S - Sale$41.30-221,250135,303-62%-$9,137,579
2017-09-08
MYOKMyokardia IncStarr Kevin PDir, 10%S - Sale$41.01-201,2507,564,156-3%-$8,252,499
D
2017-09-08
EBSEmergent Biosolutions Inc.Havey AdamEVP, Business OperationsS - Sale+OE$37.06-7,88526,046-23%-$292,243
2017-09-07
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+30,00023,292,1890%+$803
M
2017-09-06
ENDVEndonovo Therapeutics, Inc.Mann Michael ScottPres, 10%P - Purchase$0.03+132,00023,262,189+1%+$3,392
DM
2017-09-07
SUPNSupernus Pharmaceuticals IncPatrick Gregory SVP, CFOS - Sale+OE$47.60-50,00030,716-62%-$2,379,779
D
2017-09-07
SUPNSupernus Pharmaceuticals IncSchwabe Stefan K.F.EVP R, DS - Sale+OE$46.59-95,0001,855-98%-$4,425,575
2017-09-08
SUPNSupernus Pharmaceuticals IncBhatt Padmanabh P.SVP of IP, CSOS - Sale$49.86-5,00012,500-29%-$249,303
2017-09-11
ACRXAcelrx Pharmaceuticals IncAsadorian RaffiCFOP - Purchase$3.24+7,0007,000New+$22,705
D
2017-09-07
AIMTAimmune Therapeutics, Inc.Rozenman Mary M.See RemarksS - Sale+OE$22.50-30,000129-100%-$675,000
2017-09-07
PRGOPerrigo Co PlcKochan SharonEVP, GM InternationalS - Sale$81.36-31810,481-3%-$25,874

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top